Morehouse School of Medicine

The HPOs will receive $13.8 million to enroll people interested in the All of Us program, gather participant health information, and help retain participants.

The oncology data warehouse started by the Moffitt Cancer Center and Ohio State University Comprehensive Cancer Center now has nine members.

This story has been updated from a version published Aug. 15 to reflect the fact that Iverson Genetics has not yet selected a testing partner for the WARFARIN trial.

Morehouse School of Medicine will use the NIH funding and work with several partners to start a minority database focused first on hypertension and personalized medicine.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.